Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2025 Apr;92(4):277-282.
doi: 10.1111/cod.14743. Epub 2024 Dec 23.

Long-Term Observations on the European Photopatch Test Baseline Series (EPTBS) in Real Clinical Practice: 11 Years of Results in a Spanish Cohort and Suggestions for an EPTBS Update

Sofia Gómez-Martínez  1 , Magí Brufau-Cochs  1 , Javier de la Iglesia-Martín  1 , Victoria Amat-Samaranch  1 , Paula Aguilera-Peiró  1
Affiliations

Long-Term Observations on the European Photopatch Test Baseline Series (EPTBS) in Real Clinical Practice: 11 Years of Results in a Spanish Cohort and Suggestions for an EPTBS Update

Sofia Gómez-Martínez et al. Contact Dermatitis. 2025 Apr.

Abstract

Background: The European Photopatch Testing Baseline Series (EPTBS) was published in 2013. However, limited data exist regarding the real-world clinical application of the EPTBS.

Objectives: This study aims to describe the photopatch test experience with the EPTBS over 11 years at a tertiary hospital in Spain.

Methods: A retrospective chart review spanning from February 2012 to October 2023 was conducted on patients who underwent photopatch testing (PPT) with the EPTBS. Additionally, patch testing was performed on all patients according to the European recommendations.

Results: Data from 148 patients were collected, and showed a PPT positivity rate of 7.4% (n = 11). Specifically, we found a photoallergic contact dermatitis (PACD) in 11/148 patients (15 positive reactions to 8 different allergens, including one patient own's product). Of them, 87% had current relevance and non-steroidal anti-inflammatory drugs (NSAIDS) were the main culprits of PACD (60%). Alternatively, we found a contact allergy to the EPTBS allergens in 14/148 (9.3%) patients, (21 positive reactions both in the irradiated and non-irradiated set to 17 different allergens, including many patients' products). Of them, UV solar filters represented the main cause of ACD. Regarding the patch testing results, we observed a positivity rate of 39.9% (116 positives in 59 different patients). The most frequent were methylchloroisothiazolinone/methylisothiazolinone, fragrance mix I and II and Myroxylon pereirae resin (balsam of Peru).

Conclusion: EPTBS implementation has permitted a more accurate study of PACD. Our positivity rate for PPT is slightly lower than previous reports, however the main culprits for PACD remain to be NSAIDS. The inclusion of contact allergens applied in photoexposed areas in the EPTBS could contribute to discriminating between PACD, photoaggravated ACD and ACD.

Keywords: European Photopatch Test Baseline Series; photoallergic contact dermatitis; photopatch testallergic contact dermatitis.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflicts of interest.

References

    1. Kerr A. and Ferguson J., “Photoallergic Contact Dermatitis,” Photodermatology, Photoimmunology & Photomedicine 26, no. 2 (2010): 56–65, 10.1111/j.1600-0781.2010.00494.x. - DOI - PubMed
    1. Codeço C., Alves P. B., Figueiredo A. C., Flor D., and Gonçalo M., “Shedding a Light on the Importance of Photopatch Testing: A 12‐Year Experience in a Dermatology Unit,” Contact Dermatitis 88, no. 6 (2023): 438–445, 10.1111/cod.14297. - DOI - PubMed
    1. Cazzaniga S., Lecchi S., Bruze M., et al., “Development of a Clinical Score System for the Diagnosis of Photoallergic Contact Dermatitis Using a Consensus Process: Item Selection and Reliability,” Journal of the European Academy of Dermatology and Venereology 29, no. 7 (2015): 1376–1381, 10.1111/jdv.12879. - DOI - PubMed
    1. Bruynzeel D. P., Ferguson J., Andersen K., et al., “Photopatch Testing: A Consensus Methodology for Europe,” Journal of the European Academy of Dermatology and Venereology 18 (2004): 679–682, 10.1111/j.1468-3083.2004.01053.x. - DOI - PubMed
    1. Kerr A. C., Ferguson J., Haylett A. K., et al., “A European Multicentre Photopatch Test Study,” British Journal of Dermatology 166, no. 5 (2012): 1002–1009, 10.1111/j.1365-2133.2012.10857.x. - DOI - PubMed

LinkOut - more resources